Sale!

ATP6AP2 Gene Parkinsonism with Spasticity X-Linked Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATP6AP2 gene has been identified as a critical player in the development of a unique form of Parkinsonism characterized by spasticity, following an X-linked inheritance pattern. This condition, which combines features of Parkinson’s disease with muscle stiffness and spasms, has led to the development of specialized genetic testing to diagnose the disorder accurately.

The genetic test for ATP6AP2 gene-related Parkinsonism with spasticity is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test specifically targets mutations within the ATP6AP2 gene to confirm the diagnosis, enabling healthcare professionals to tailor treatment and management plans for affected individuals.

Priced at 4400 AED, the test is a valuable tool for families with a history of X-linked Parkinsonism with spasticity, offering them a clear understanding of their genetic status. This information is crucial for making informed decisions about future healthcare and for understanding the risk to other family members.

Description

ATP6AP2 Gene Parkinsonism with spasticity X-linked Genetic Test

Test Name: ATP6AP2 Gene Parkinsonism with spasticity X-linked Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ATP6AP2 Gene Parkinsonism with spasticity, X-linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP6AP2 Gene Parkinsonism with spasticity, X-linked.

Test Details:

The ATP6AP2 gene is associated with a rare genetic condition called ATP6AP2 gene-related parkinsonism with spasticity, which is inherited in an X-linked pattern. This means that the condition primarily affects males, while females are usually carriers of the gene mutation.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of ATP6AP2 gene-related parkinsonism with spasticity, NGS genetic testing can be used to identify mutations or variations in the ATP6AP2 gene that may be responsible for the development of the condition.

NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help confirm the presence of ATP6AP2 gene mutations, determine the specific mutation type, and assess the risk of passing on the mutation to future generations.

If you suspect ATP6AP2 gene-related parkinsonism with spasticity in yourself or a family member, it is recommended to consult with a healthcare professional or a genetic counselor. They can guide you through the process of genetic testing and help interpret the results in the context of your specific situation.

Test Name	ATP6AP2 Gene Parkinsonism with spasticity X-linked Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ATP6AP2 Gene Parkinsonism with spasticity, X-linked NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP6AP2 Gene Parkinsonism with spasticity, X-linked
Test Details	The ATP6AP2 gene is associated with a rare genetic condition called ATP6AP2 gene-related parkinsonism with spasticity, which is inherited in an X-linked pattern. This means that the condition primarily affects males, while females are usually carriers of the gene mutation. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of ATP6AP2 gene-related parkinsonism with spasticity, NGS genetic testing can be used to identify mutations or variations in the ATP6AP2 gene that may be responsible for the development of the condition. NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help confirm the presence of ATP6AP2 gene mutations, determine the specific mutation type, and assess the risk of passing on the mutation to future generations. If you suspect ATP6AP2 gene-related parkinsonism with spasticity in yourself or a family member, it is recommended to consult with a healthcare professional or a genetic counselor. They can guide you through the process of genetic testing and help interpret the results in the context of your specific situation.